PharmaShots | Incisive News in 3 Shots

Subscribe Now

Axsome Therapeutics

PharmaShots Weekly Snapshots (March 26 – March 29, 2024)

PharmaShots Weekly Snapshots (March 26 – March 29, 2024)

March 29, 2024

Axsome Therapeutics Reports Results for AXS-12 in P-III Trial for the Treatment of Narcolepsy

Axsome Therapeutics Reports Results for AXS-12 in P-III Trial for the Treatment of Narcolepsy

March 26, 2024

Axsome Therapeutics Reports the First Patient Dosing of Solriamfetol in the P-III Trial (FOCUS) for Adults with Attention Deficit Hyperactivity Disorder

Axsome Therapeutics Reports the First Patient Dosing of Solriamfetol in the P-III Trial (FOCUS) for Adults with Attention Deficit...

July 10, 2023

Axsome Therapeutics Entered into an Exclusive License Agreement with Pharmanovia to Develop and Commercialize Sunosi (solriamfetol) in Europe

Axsome Therapeutics Entered into an Exclusive License Agreement with Pharmanovia to Develop and Commercialize Sunosi (solriamfetol...

February 23, 2023

axsome Therapeutics Reports P-III (ACCORD) Trial Results of AXS-05 for the Treatment of Alzheimer’s Disease Agitation

axsome Therapeutics Reports P-III (ACCORD) Trial Results of AXS-05 for the Treatment of Alzheimer’s Disease Agitation

November 29, 2022

PharmaShots Weekly Snapshot (Dec 30, 2019-Jan 03, 2020)

PharmaShots Weekly Snapshot (Dec 30, 2019-Jan 03, 2020)

January 6, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us